Patients suffering from chronic illness are often eager to participate in clinical trials with the hopes of finding a more effective treatment for themselves and others with their condition. This is especially true in the case of rare diseases, as these trials are often seen as a patient’s only opportunity for treatment. Unfortunately, various logistical, financial, and emotional barriers, like geographic location and travel-related costs, prevent patients from enrolling in trials and accessing life-changing medicine. Because of this, patient recruitment and retention continue to be challenges for the industry despite the best efforts of Clinical Research Organizations (CROs) and pharmaceutical trial sponsors.